MDPA
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | methylenedioxyphenylacetamide | — | |
| Safety | |||
| Dose · Oral | |||
| Light | 75–125 mg | — | |
| Common | 125–175 mg | — | |
| Strong | 175–250 mg | — | |
| Duration | |||
| Onset | 15–45 minutes | — | |
| Total | 2–4 hours | — | |
| Pharmacology | |||
TripSit summary
An obscure substituted methylenedioxyphenethylamine with practically no history of human use. Its pharmacological profile is largely unknown, but potentially exhibits similar properties to other MDxx compounds. May be a monoamine releaser, reuptake inhibitor or both.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.